Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Operating Margin
Operating income as a percentage of revenue, showing the profitability of core operations.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Operating Margin · Q2 FY2026 · quarter ended Jun 2026
Operating margin narrows to -13.6%
Operating margin was -13.6% in Q2 FY2026, down 51.6 pp from a year earlier. On a trailing-twelve-month basis it was 15.3%, down 21.7 pp year over year. Over 3 fiscal years it narrowed by 3.5 pp.
Context
- Operating margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether operating margin reaches the consensus estimate from 4 analysts of 23.7% for the fiscal year ending Dec 2026, down from 34.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- -13.6%-31.4 pp QoQ
- Last fiscal yearDec 2025
- 34.1%-2.5 pp YoY
- LTMJun 2026
- 15.3%-21.7 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -51.6 pp | +3.7 pp | +55.4 pp |
| 1 year | -2.5 pp | -10.4 pp | -7.9 pp |
| 3 years | -3.5 pp | -3.3 pp | +0.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 34.1%
- Year-over-year change
- -2.5pp
| Period | Period end | Operating Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 34.1% | -2.5pp |
| FY2024 | 2024-12-31 | 36.5% | +2.3pp |
| FY2023 | 2023-12-31 | 34.2% | -3.3pp |
| FY2022 | 2022-12-31 | 37.6% | +0.6pp |
| FY2021 | 2021-12-31 | 37.0% | — |
Operating Margin vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 operating margin of 15.3% is the 6th highest of the 11 companies compared; the peer median is 11.9%.
- Its year-over-year change of -21.7 pp is the lowest of 9, against a peer median of -0.5 pp.
- Over three fiscal years its change of -3.5 pp compares with a peer median of +3.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 64.0% | +8.3 pp | +11.8 pp | |
| LTM Jun 2026 | 62.4% | +0.1 pp | +17.9 pp | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | 56.6% | +10.9 pp | -9.5 pp |
| LTM Sep 2026 | 39.9% | -11.8 pp | +3.7 pp | |
| LTM Sep 2026 | 17.3% | -1.3 pp | +2.0 pp | |
| LTM Jun 2026 | 15.3% | -21.7 pp | -3.5 pp | |
| LTM Sep 2026 | 6.5% | -1.2 pp | +1.9 pp | |
| LTM Sep 2026 | 4.5% | -11.7 pp | -9.6 pp | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | 1.0% | — | +10.4 pp |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | 0.1% | +31.2 pp | +10.4 pp |
| FY2025 | -12.2% | — | — | |
| Peer median (excluding SBRA) | 11.9% | -0.5 pp | +3.7 pp | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.